{"id":"W4400655270","doi":"10.3899/jrheum.2024-0540","title":"Canadian Rheumatology Association Living Guidelines for Rheumatoid Arthritis: Update #2","year":2024,"lang":"en","type":"letter","venue":"The Journal of Rheumatology","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Memorial University of Newfoundland; McMaster University; Toronto General Hospital; University of Saskatchewan; Canadian Rheumatology Association; University of Calgary; Mount Sinai Hospital; Bombardier (Canada); University Health Network; Dalhousie University; University of British Columbia; Canadian Arthritis Patient Alliance; University of Toronto; Western University; Research Canada; McGill University; University of Ottawa; Cochrane","funders":"Health Canada; Celgene; Biogen; Gilead Sciences; Celltrion; Sanofi; Amgen; Pfizer; Canadian Rheumatology Association; Eli Lilly and Company","keywords":"Rheumatoid arthritis; Rheumatology; Medicine; Internal medicine; Antirheumatic drugs; Physical therapy; Antirheumatic Agents","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":true,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00296729,0.0008194786,0.001230765,0.00256614,0.002297713,0.002678655,0.002172647,0.008810888,0.02839388],"category_scores_gemma":[0.01595324,0.0004755043,0.001286308,0.002197469,0.001207611,0.001738561,0.001170735,0.01033045,0.02159689],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01072608,"about_ca_system_score_gemma":0.02962774,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.2535423,"about_ca_topic_score_gemma":0.4206494,"domain_scores_codex":[0.9955402,0.0005636652,0.0005348805,0.000140471,0.002700282,0.0005205063],"domain_scores_gemma":[0.9805921,0.001965053,0.0007768829,0.0002907707,0.01456731,0.001807832],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000005738975,0.00000683731,0.00009376012,0.00007571313,0.00000247892,0.0001052401,0.00001344291,0.00001169008,0.00002239024,0.0003267404,0.9848231,0.01451267],"study_design_scores_gemma":[0.00002781989,0.000004065254,0.0005264154,0.0005039368,0.000008922386,0.0005067825,0.00003073388,0.00003303921,0.00001687748,0.0004668625,0.9978636,0.00001105798],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"other","genre_scores_codex":[0.000534659,0.08529697,0.0009873119,0.7235102,0.06756531,0.0002698161,0.004044738,0.0004090018,0.117382],"genre_scores_gemma":[0.009806355,0.1696293,0.008628242,0.5439692,0.08304475,0.0005617659,0.01645863,0.0003757133,0.1675261],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.9892739,"threshold_uncertainty_score":0.5041331,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02453376340986835,"score_gpt":0.3009462532007559,"score_spread":0.2764124897908875,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}